FFF Enterprises Launches New, Improved Website
Press Release for July 21, 2009
The nation’s most trusted distributor of plasma products, vaccines and other critical-care biopharmaceuticals debuts newly enhanced website as a valuable source of information, education and online ordering.
July 21, 2009 – FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, announced today that it has redesigned its corporate website (www.FFFenterprises.com). The site, which went live today, features enhanced capabilities, a more intuitive design and prominently displays the company’s key marketing messages for its various business units.
“The new site is more reflective of who we are as a company and our recognized position as an industry leader and innovator,” says Sheryl Perez, vice president marketing, FFF Enterprises, Inc. “One of our goals was to make the site easier to use for our customers and manufacturing partners, to create stronger landing pages for each of our business units, and to streamline content in a way that makes it faster for visitors to access the information they need.”
FFF’s new website highlights the company’s safety-first best practices model, “The Eight Critical Steps to Guaranteed Channel Integrity™,” and a micro site accessible from the corporate home page summarizes the issues that threaten a secure pharmaceutical supply chain, along with an in-depth look at FFF’s response. This level of commitment and transparency are fundamental to the company’s flawless safety track record. Other features of the site include a comprehensive product listing for customers, helpful resource links to information on seasonal flu, state pedigree requirements and reference charts, and links to FFF’s various programs.
The site re-launch coincides with the company’s July anniversary as it commemorates 21 counterfeit-free years in the biopharmaceuticals industry. The accomplishment is a significant one, since the pharmaceutical supply chain has long been vulnerable to counterfeiting, price gouging and inferior management of fragile plasma derivatives and other specialty products. Thanks to FFF’s innovative business model and commitment to “helping healthcare care,” that supply chain is significantly safer today than it was two decades ago.
“We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “Our customers recognize the value of channel integrity to their patients and their bottom lines. Our website is a valuable platform to clearly communicate and educate our customers on each of the steps that are critical to achieving this standard.”
Another example of FFF’s quality commitment is epitomized by its specialty pharmacy subsidiary, NuFACTOR, which was established to provide IVIG, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica, which provide revolutionary approaches to vaccination for healthcare providers and patients respectively, and include streamlining access to and administration of preventive vaccines.
FFF is recognized as the most trusted distributor of biopharmaceuticals, plasma products and vaccines in the nation, serving over 80% of U.S. hospitals and supplying the nation’s leading non-acute care group purchasing organizations. And while FFF is primarily a biopharmaceutical distributor, the company’s overriding commitment is as much to the healthcare provider as it is to the patient.
About FFF Enterprises, Inc.
FFF Enterprises, Inc., a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 20th year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to licensed healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF’s MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.